AGIOS PHARMACEUTICALS, INC. Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for February 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 28 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 47.12 | 472 | 22,241 | 184 | 656 to 184 (-71.95 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,333 | 0 | 6,667 | |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 48.66 | 1,056 | 51,385 | 16,518 | 17.6 K to 16.5 K (-6.01 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 3,333 | 0 | 17,574 | 14.2 K to 17.6 K (+23.40 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,333 | 0 | 6,667 | |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 48.66 | 1,596 | 77,661 | 5,318 | 6.9 K to 5.3 K (-23.08 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 3,333 | 0 | 6,914 | 3.6 K to 6.9 K (+93.07 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 2,775 | 0 | 5,549 | |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Payment of Exercise | F | 48.66 | 880 | 42,821 | 105,053 | 105.9 K to 105.1 K (-0.83 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 2,775 | 0 | 105,933 | 103.2 K to 105.9 K (+2.69 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 0.00 | 691 | 0 | 1,383 | |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Payment of Exercise | F | 48.66 | 219 | 10,657 | 656 | 875 to 656 (-25.03 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 0.00 | 691 | 0 | 875 | 184 to 875 (+375.54 %) |
Feb 24 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 53.37 | 2,427 | 129,529 | 184 | 2.6 K to 184 (-92.95 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 0.00 | 2,800 | 0 | 0 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 0.00 | 790 | 0 | 790 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 51.51 | 5,332 | 274,651 | 5,332 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 0.00 | 4,800 | 0 | 4,800 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 0.00 | 2,666 | 0 | 2,666 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Payment of Exercise | F | 52.01 | 1,163 | 60,488 | 2,611 | 3.8 K to 2.6 K (-30.82 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 0.00 | 2,800 | 0 | 3,774 | 974 to 3.8 K (+287.47 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 0.00 | 790 | 0 | 974 | 184 to 974 (+429.35 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 2,750 | 0 | 2,750 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 51.51 | 45,000 | 2,317,950 | 45,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 52.01 | 819 | 42,596 | 3,581 | 4.4 K to 3.6 K (-18.61 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 2,750 | 0 | 4,400 | 1.7 K to 4.4 K (+166.67 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 0.00 | 34,000 | 0 | 34,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 51.51 | 137,000 | 7,056,870 | 137,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,750 | 0 | 2,750 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 51.51 | 45,000 | 2,317,950 | 45,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 52.01 | 886 | 46,081 | 14,241 | 15.1 K to 14.2 K (-5.86 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 2,750 | 0 | 15,127 | 12.4 K to 15.1 K (+22.22 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 8,125 | 0 | 8,125 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Payment of Exercise | F | 52.01 | 2,534 | 131,793 | 103,158 | 105.7 K to 103.2 K (-2.40 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 8,125 | 0 | 105,692 | 97.6 K to 105.7 K (+8.33 %) |
Feb 13 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 621 | 21,834 | 26,406 | |
Feb 13 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.02 | 621 | 31,063 | 1,650 | 2.3 K to 1.7 K (-27.34 %) |
Feb 13 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 621 | 21,834 | 2,271 | 1.7 K to 2.3 K (+37.64 %) |
Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 35,447 | 1,246,317 | 27,027 | |
Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 8,526 | 299,774 | 62,474 | |
Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.10 | 35,447 | 1,776,026 | 1,650 | 37.1 K to 1.7 K (-95.55 %) |
Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 35,447 | 1,246,317 | 37,097 | 1.7 K to 37.1 K (+2,148.30 %) |
Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.03 | 14,191 | 709,963 | 1,650 | 15.8 K to 1.7 K (-89.58 %) |
Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 8,526 | 299,774 | 15,841 | 7.3 K to 15.8 K (+116.56 %) |